Back to today’s briefing

Story perspectives

Novartis Secures Tariff Deal Amid $23B U.S. Investment

1/20/2026

43 4 Full Breakdown

Summary

Story summary

Novartis CEO Vas Narasimhan said the company has an agreement with the United States to avoid tariffs.
Speaking at Davos, he cited a $23 billion manufacturing investment as protection against levies.
The statement follows U.S. President Donald Trump’s 10% tariff on several European countries, rising to 25% by June 1, linked to his Greenland campaign.
In 2025, EU pharmaceutical exports to the United States totaled 84.4 billion euros.

1 of 1

Story summary

Novartis CEO Vas Narasimhan said the company has an agreement with the United States to avoid tariffs.
Speaking at Davos, he cited a $23 billion manufacturing investment as protection against levies.
The statement follows U.S. President Donald Trump’s 10% tariff on several European countries, rising to 25% by June 1, linked to his Greenland campaign.
In 2025, EU pharmaceutical exports to the United States totaled 84.4 billion euros.